A Worldwide Leading PEG Supplier
2019 was a very exciting year with three ADC drugs approved by FDA, followed by one more new ADC, Sacituzumab Govitecan (IMMU-132) approved in 2020 from Immunomedics. IMMU-132, also known as Trodelvy, is an immune targeted therapy medicine for triple-negative breast cancer. The drug consists of sacituzumab and SN-38 with a linker in between. Sacituzumab […]
A collaboration from Harvard Medical School, Dana-Farber Cancer Institute, Moderna Therapeutics and more looked into how small molecules can block the viral replication cycle at an early stage of flaviviruses, which also includes the dengue virus. There has been an unmet medical need to prevent flavivirus infections since there are no approved drugs to prevent […]
Recently published by the School of Medicine of Stanford University, researchers have been looking into new ways to improve stem cell therapy by decreasing the time, risk and cost. During the process, they have created an experimental design involving click-chemistry and glycoengineering to test different kinds of stiffness of the polymer coating in order to […]
Powered by WordPress. AwesomeOne theme by Flythemes